Erschienen in:
04.09.2020 | IM - COMMENTARY
Cryoglobulinemic vasculitis: having giant steps; but there are still unanswered questions
verfasst von:
Omer Karadag, Emine Duran
Erschienen in:
Internal and Emergency Medicine
|
Ausgabe 1/2021
Einloggen, um Zugang zu erhalten
Excerpt
Cryoglobulinemic vasculitis (CryoVas) is a systemic immune-complex vasculitis which can be a life-threatening condition. In their article recently published by Internal and Emergency Medicine, Vacchi C et al. reported the safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of CryoVas [
1]. For a better understanding of this article, an overarching look to the historical picture of CryoVas and details of the usage of biosimilars will be helpful. …